A Study For Patients With EGFRm (Epidermal Growth Factor Receptor Mutant) Lung Cancer

Clinical trial NCT02297425 · WITHDRAWN

Trial details

NCT number: NCT02297425
Sponsor: Pfizer
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced EGFRm (Del 19 or L858R +/- T790M) NSCLC

Start date: 2015-01-01
Primary completion: 2018-03-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.